NEWS & EVENTS

Company News - Press Releases - Events - Publications

EpimiRNA FP7 Grant: working to improve lives of patients

Bicoll brings in its medicinal chemistry competence as an active participant of EpimiRNA project. A first novel lead structure preventing seizures in a human tissue model could be provided through the consortium efforts. Furthermore, there are a number of results achieved already such as identification of new microRNAs, that control brain excitability etc. There are new commercial opportunities created: spin-out, medical device and drug development program to create drugs of the future are currently exploited. More is on the way (https://twitter.com/epimirna)

Questions? Get in touch!

We would love talking to you:

Bicoll GmbH
Headquarters
Am Klopferspitz 19
82152 Planegg/Martinsried
Germany
+49 (0)89 820 106 30


Important
This Site uses cookies, which could include third-party cookies, to ensure its technical functioning and which may contain tracking information about visitors. By continuing to browse this site you agree to our use of cookies. If you want to learn more about our Privacy Policy click here.